Monitoring tryptophan metabolism in chronic immune activation

doi:10.1016/j.cca.2005.06.013

Clinica Chimica Acta

Volume 364, Issues 1–2, February 2006, Pages 82-90

https://doi.org/10.1016/j.cca.2005.06.013 Get rights and content

Abstract

The essential amino acid tryptophan is a constituent of proteins and is also a substrate for two important biosynthetic pathways: the generation of neurotransmitter 5-hydroxytryptamine (serotonin) by tryptophan 5-hydroxylase, and the formation of kynurenine derivatives and nicotinamide adenine dinucleotides. The latter pathway is initiated by the enzymes tryptophan pyrrolase (tryptophan 2,3-dioxygenase, TDO) and indoleamine 2,3-dioxygenase (IDO). TDO is located in liver cells, whereas IDO is expressed in a variety of cells including monocyte-derived macrophages and dendritic cells and is preferentially induced by Th1-type cytokine interferon-γ. Tryptophan depletion via IDO is part of the cytostatic and antiproliferative activity mediated by interferon-γ in cells. In vivo tryptophan concentration can be measured by HPLC by monitoring its natural fluorescence (285 nm excitation and 365 nm emission wavelength). IDO activity is characterized best by the kynurenine to tryptophan ratio which correlates with concentrations of immune activation markers such as neopterin. Low serum/plasma tryptophan concentration is observed in infectious, autoimmune, and malignant diseases and disorders that involve cellular (Th1-type) immune activation as well as during pregnancy due to accelerated tryptophan conversion. Thus, in states of persistent immune activation, low tryptophan concentration may contribute to immunodeficiency. Decreased serum tryptophan can also effect serotonin biosynthesis and thus contribute to impaired quality of life and depressive mood. As such, monitoring tryptophan metabolism in chronic immunopathology provides a better understanding of the association between immune activation and IDO and its role in the development of immunodeficiency, anemia and mood disorders.

Section snippets

Tryptophan metabolism

The essential amino acid l-tryptophan is required for the biosynthesis of proteins and is precursor for several biologically important compounds (Fig. 1): (a) 5-hydroxytryptamine (serotonin) which is formed by tryptophan (5)-hydroxylase (EC 1.14.16.4) following decarboxylation; (b) tryptophan (2,3)-dioxygenase (TDO, tryptophan pyrrolase, EC 1.13.1.2); and (c) indoleamine (2,3)-dioxygenase (IDO, EC 1.13.11.42). The latter two catabolize tryptophan via the so-called kynurenine-pathway

IDO to limit cellular growth via tryptophan deprivation

The pro-inflammatory cytokine IFN-γ induces the enzyme IDO in a variety of cells [15]. IDO activation limits availability of tryptophan (Fig. 2). Because tryptophan is required for protein synthesis, withdrawal of this essential amino acid from the micro-environment arrests protein biosynthesis and subsequent growth of pathogens and proliferating cells (Fig. 3). Consequently, tryptophan depletion is regarded as a defense mechanism induced by IFN-γ in immunocompetent cells during immune

Measurement of tryptophan and kynurenine

Tryptophan measurement in serum, plasma and other body fluids is performed by HPLC using reversed phase C18 columns [14], [25]. A pre-column is advantageous to protect the C18 separation column from apolar materials of biologic origin. Tryptophan is easily monitored by its natural fluorescence at an excitation wavelength of 285 nm and an emission wavelength of 365 nm. To accurately assess rate of tryptophan degradation, it is necessary to additionally analyze the concentration of the first

Accelerated tryptophan catabolism due to IDO activation in patients

In various diseases (Table 2), decreased tryptophan concentration and increased concentrations of kynurenine and other tryptophan catabolites such as quinolinic acid have been described [9], [10], [11], [12], [13], [15], [27]. The correlation found between neopterin concentration and kyn / trp ratio (Fig. 4) suggests that an increased endogenous production of IFN-γ takes place under these conditions. This finding supports the conclusion that activation of IDO is involved in enhanced rate of

Pathogenetic effects related to accelerated tryptophan degradation

IFN-γ is probably the most important antiproliferative cytokine released during Th1-type immune response. It induces several biochemical pathways and mechanisms in order to stop growth of microbes and tumor cells. Because of its outstanding potency it is not surprising to find side effects especially during clinical conditions of continuous immune system stimulation and IFN-γ production which may exert strong negative impact on cells of the host [56].

Treatment options to counteract accelerated tryptophan degradation

Until the late 1980's, supplementation of tryptophan was used to correct sleep disturbances. Supplementation in patients with accelerated tryptophan catabolism is, however, hampered by increased production of potentially harmful products such as quinolinic acid. Tryptophan supplementation also circumvents the antiproliferative strategy of the immune system and it is unclear whether tryptophan supplementation would up-regulate malignant cell growth in cancer patients. On the other hand,

Conclusion

Measurement of tryptophan and kynurenine concentration and calculated kyn / trp ratio will be instrumental to clarify the relationship between immune activation and tryptophan degradation especially in chronic disease. This premise is fundamental to the study of interaction within the neuroimmunoendocrine network and the role of IDO in stimulated monocyte-derived macrophages and dendritic cells and their relationship to immunodeficiency, anemia and cachexia. Because of the biochemical importance

Acknowledgements

This work was supported by the Austrian Federal Ministry of Social Affairs and Generations. The authors thank Miss Astrid Haara for excellent technical assistance.

References (76)

E.R. Werner et al.
Human macrophages degrade tryptophan upon induction by interferon gamma
Life Sci
(1987)
G. Werner-Felmayer et al.
Characteristics of interferon induced tryptophan metabolism in human cells in vitro
Biochim Biophys Acta
(1989)
U. Grohmann et al.
Tolerance, DCs and tryptophan: much ado about IDO
Trends Immunol
(2003)
D. Fuchs et al.
Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation
Immunol Lett
(1989)
R. Zangerle et al.
Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection
Clin Immunol
(2002)
A.M. Wolf et al.
Overexpression of indoleamine 2,3-dioxygenase (IDO) in human inflammatory bowel disease
Clin Immunol
(2004)
K. Schroecksnadel et al.
Tryptophan degradation in patients with gynecological cancer correlates with immune activation
Cancer Lett
(2005)
B. Widner et al.
Enhanced tryptophan degradation in systemic lupus erythematosus
Immunobiology
(2000)
B. Frick et al.
Increasing production of homocysteine and neopterin and degradation of tryptophan with older age
Clin Biochem
(2004)
C. Murr et al.
Immune reaction links disease progression in cancer patients with depression
Med Hypotheses
(2000)

B. Widner et al.

Neopterin production tryptophan degradation and mental depression: what is the link?

Brain Behav Immun

(2002)

M. Maes et al.

Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response

Psych Res

(1994)

M.F. Murray

Tryptophan depletion and HIV infection: a metabolic link to pathogenesis

Lancet Infect Dis

(2003)

S.G. Cady et al.

1-Methyl-dl-tryptophan, beta-(3-benzofuranyl)-dl-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-dl-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

Arch Biochem Biophys

(1991)

C. Murr et al.

Antioxidants may increase the probability of developing allergic diseases and asthma

Med Hypotheses

(2005)

D.A. Bender

The relative importance of dietary tryptophan and preformed nicotinic acid and nicotinamide as precursors of nicotinamide nucleotide coenzymes

R. Yoshida et al.

Induction of pulmonary indoleamine (2,3)-dioxygenase by interferon

Proc Natl Acad Sci U S A

(1981)

M.W. Taylor et al.

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism

FASEB J

(1991)

P. Hwu et al.

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

J Immunol

(2000)

G.I. Byrne et al.

Induction of tryptophan degradation in vitro and in vivo: a gamma interferon stimulated activity

J Interferon Res

(1986)

G. Weiss et al.

Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells

Clin Exp Immunol

(1999)

E.R. Werner et al.

Tryptophan degradation in patients infected by human immunodeficiency virus

Biol Chem Hoppe-Seyler

(1988)

D. Fuchs et al.

Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms

J Aquir Immune Defic Syndr

(1990)

B. Wirleitner et al.

Immune activation and degradation of tryptophan in coronary heart disease

Eur J Clin Invest

(2003)

H. Denz et al.

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

Clin Investig

(1993)

M.P. Heyes et al.

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

Brain

(1992)

B. Widner et al.

Simultaneous measurement of serum tryptophan and kynurenine by HPLC

Clin Chem

(1997)

B. Wirleitner et al.

Interferon-?-induced conversion of tryptophan: immunologic and neuropsychiatric aspects

Curr Med Chem

(2003)

E.R. Pfefferkorn

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

Proc Natl Acad Sci U S A

(1984)

L.M. de la Maza et al.

Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media

Cancer Res

(1988)

Y. Ozaki et al.

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

Proc Natl Acad Sci U S A

(1988)

D.H. Munn et al.

Inhibition of T cell proliferation by macrophage tryptophan catabolism

J Exp Med

(1999)

D.H. Munn et al.

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

Science

(2002)

P. Terness et al.

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

J Exp Med

(2002)

G. Frumento et al.

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase

J Exp Med

(2002)

A. Laich et al.

More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC

Clin Chem

(2002)

N.K. Steckel et al.

Indoleamine 2,3-dioxygenase expression in monocytes of healthy nonpregnant women after induction with human choriongonadotropine

Scand J Immunol

(2005)

B. Widner et al.

Interferon-gamma-induced tryptophan degradation: neuropsychiatry and immunological consequences

Curr Drug Metabol

(2000)

Cited by (475)

Exploring environmental exposomes and the gut-brain nexus: Unveiling the impact of pesticide exposure
2024, Environmental Research
This review delves into the escalating concern of environmental pollutants and their profound impact on human health in the context of the modern surge in global diseases. The utilisation of chemicals in food production, which results in residues in food, has emerged as a major concern nowadays. By exploring the intricate relationship between environmental pollutants and gut microbiota, the study reveals a dynamic bidirectional interplay, as modifying microbiota profile influences metabolic pathways and subsequent brain functions. This review will first provide an overview of potential exposomes and their effect to gut health. This paper is then emphasis the connection of gut brain function by analysing microbiome markers with neurotoxicity responses. We then take pesticide as example of exposome to elucidate their influence to biomarkers biosynthesis pathways and subsequent brain functions. The interconnection between neuroendocrine and neuromodulators elements and the gut-brain axis emerges as a pivotal factor in regulating mental health and brain development. Thus, manipulation of gut microbiota function at the onset of stress may offer a potential avenue for the prevention and treatment for mental disorder and other neurodegenerative illness.
Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: The Nor-COAST study
2024, Brain, Behavior, and Immunity
We have previously shown that systemic inflammation was associated with post-stroke cognitive impairment (PSCI). Because neopterin, kynurenine pathway (KP) metabolites, and B6 vitamers are linked to inflammation, in our study we investigated whether those biomarkers were associated with PSCI.
The Norwegian Cognitive Impairment After Stroke study is a prospective multicenter cohort study of patients with acute stroke recruited from May 2015 through March 2017. Plasma samples of 422 participants (59 % male) with ischemic stroke from the index hospital stay and 3 months post-stroke were available for analyses of neopterin, KP metabolites, and B6 vitamers using liquid chromatography–tandem mass spectrometry. Mixed linear regression analyses adjusted for age, sex, and creatinine, were used to assess whether there were associations between those biomarkers and cognitive outcomes, measured by the Montreal Cognitive Assessment scale (MoCA) at 3-, 18-, and 36-month follow-up.
Participants had a mean (SD) age of 72 (12) years, with a mean (SD) National Institutes of Health Stroke Scale score of 2.7 (3.6) at Day 1. Higher baseline values of quinolinic acid, PAr (i.e., an inflammatory marker based on vitamin B6 metabolites), and HKr (i.e., a marker of functional vitamin B6 status based on selected KP metabolites) were associated with lower MoCA score at 3, 18, and 36 months post-stroke (p < 0.01). Higher baseline concentrations of neopterin and 3-hydroxykynurenine were associated with lower MoCA scores at 18 and 36 months, and higher concentrations of xanthurenic acid were associated with higher MoCA score at 36 months (p < 0.01). At 3 months post-stroke, higher concentrations of neopterin and lower values of pyridoxal 5́-phosphate were associated with lower MoCA scores at 18- and 36-month follow-up, while lower concentrations of picolinic acid were associated with a lower MoCA score at 36 months (p < 0.01).
Biomarkers and metabolites of systemic inflammation, including biomarkers of cellular immune activation, indexes of vitamin B6 homeostasis, and several neuroactive metabolites of the KP pathway, were associated with PSCI.
Trial registration: ClinicalTrials.gov: NCT02650531.
Longitudinal characterization of the metabolome of dairy cows transitioning from one lactation to the next: Investigations in blood serum
2024, Journal of Dairy Science
The objective of this study was to characterize changes in the serum metabolome and various indicators of oxidative balance in dairy cows starting 2 wk before dry-off and continuing until wk 16 of lactation. Twelve Holstein dairy cows (body weight 745 ± 71 kg, body condition score 3.43 ± 0.66; mean ± SD) were housed in a tiestall barn from 10 wk before to 16 wk after parturition. Cows were dried off 6 wk before the expected calving date (mean dry period length = 42 d). From 8 wk before calving to 16 wk after calving, blood samples were taken weekly to study redox metabolism by determining antioxidant capacity, measured as the ferric-reducing ability of plasma, reactive oxidative metabolites, oxidative stress index, oxidative damage of lipids, measured as thiobarbituric acid reactive substances, and glutathione peroxidase activity. According to these results, dairy cows had the lowest serum antioxidant capacity and greater levels of oxidative stress during the dry-off period and the early postpartum period. For metabolomics, a subset of serum samples including wk −7 (before dry-off), −5 (after dry-off), −1, 1, 5, 10, and 15 relative to calving were used. A targeted metabolomics approach was performed using liquid chromatography and flow injection with electrospray ionization triple quadrupole mass spectrometry using the MxP Quant 500 kit (Biocrates Life Sciences AG). A total of 240 metabolites in serum were used in the final data analysis. Principal component analysis revealed a clear separation by days of sampling, indicating a remarkable shift in metabolic phenotype between the dry period and late and early lactation. Changes in many non-lipid metabolites associated with one-carbon metabolism, the tricarboxylic acid cycle, the urea cycle, and AA catabolism were observed in the study, with changes in AA serum concentrations likely related to factors such as energy and nitrogen balance, digestive efficiency, and changing diets. The study confirmed an extensive remodeling of the serum lipidome in peripartum dairy cows, highlighting the importance of changes in acylcarnitine (acylCN), phosphatidylcholines (PC), and triacylglycerols (TG), as they play a crucial role in lipid metabolism. Results showed that short-chain acylCN increased after dry-off and decreased thereafter, whereas lipid-derived acylCN increased around parturition, suggesting that more fatty acids could enter mitochondria. Phospholipids and sphingolipids in serum showed changes during lactation. In particular, concentrations of sphingomyelins, PC, and lysoPC decreased around calving but increased in mid- and late lactation. In contrast, concentrations of TG remained consistently low after parturition. The serum concentrations of bile acids fluctuated during the dry period and lactation, with glycocholic acid, cholic acid, glycodeoxycholic acid, and taurocholic acid showing the greatest concentrations. These changes are likely due to the interplay of diet, liver function, and the ability of the gut microbiota to convert primary to secondary bile acids. Overall, these descriptive results may aid in hypothesis generation and in the design and interpretation of future metabolite-based studies in dairy cows. Furthermore, they contribute to our understanding of the physiological ranges in serum metabolites relative to the lactation cycle of the dairy cow.
Accelerated kynurenine pathway downregulates immune activation in patients with axial spondyloarthritis
2023, Cytokine
Various studies reported that the kynurenine (Kyn) pathway plays a pivotal role in regulating the balance between activation and inhibition of the immune system. Proinflammatory cytokines can accelerate the Kyn pathway by altering indoleamine (2, 3)- dioxygenase (IDO) allosteric enzyme activity. Excessive cytokine release and immune system activation have essential roles in the pathogenesis of axial spondyloarthritis (axSpA). We aimed to investigate the relationship of the Kyn pathway with proinflammatory cytokines and with the severity of the disease in patients with axSpA.
The study included 104 patients with axSpA and 54 healthy volunteers. The severity of the disease was determined by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The Kyn pathway was evaluated by IDO activity calculated with Kyn/Tryptophan (Trp) ratio. Plasma Trp and Kyn concentrations were measured with tandem mass spectrometry. Serum IL 17/23 and IFN-γ concentrations were measured with ELISA. These groups were compared in terms of IDO, IL-17, IL-23, IFN-γ, and BASDAI.
Plasma IDO activity was significantly increased, however, serum IL-17, IL-23, and IFN-γ levels were significantly decreased in patients compared to healthy volunteers. While IFN-γ was positively correlated with the severity of the disease (p = 0.02), it also had a significant inverse correlation with IDO activity (p < 0.001). However, these correlations are weak.
As a result of this study, the Kyn pathway is accelerated and proinflammatory cytokine levels are decreased in patients with axSpA. All of these results with an indirect weak negative association between high IDO and low disease activity suggest that an accelerated Kyn pathway may limit the immune system activation in axSpA disease.
The neurotoxic branch of the kynurenine pathway is highly activated in the central nervous system of patients with pneumococcal meningitis
2023, Cytokine
Acute bacterial meningitis (ABM) causes excessive activation of N-methyl-D-aspartate receptors (NMDAr), leading to cortical and hippocampal neuron death. As opposite, enteroviral meningitis is more frequently benign. The kynurenine (KYN) pathway is the major catabolic route of tryptophan (TRP) and some of its metabolites are agonists or antagonists of NMDAr.
In order to investigate the pathogen-specific patterns of KYN pathway modulation in the central nervous system of children with acute meningococcal (MM), pneumococcal (PM) or enteroviral (VM) meningitis, the cerebrospinal fluid (CSF) concentrations of TRP, KYN, kynurenic acid (KYNA) and quinolinic acid (QUINA) were evaluated by ultra-high performance liquid chromatography (uHPLC) coupled to mass spectrometry. In addition, CSF levels of IL-6, IL-10 and TNF-α were quantified by multi-analyte flow assay. The data was mined and integrated using statistical and machine learning methods.
The three forms of meningitis investigated herein up-regulated the neurotoxic branch of the KYN pathway within the intrathecal space. However, this response, represented by the concentration of QUINA, was six and nine times higher in PM patients compared to MM or VM, respectively. CSF levels of IL-6, TNF-α, and IL-10 were increased in MM and PM patients when compared to controls. In VM, CSF IL-6 and IL-10, but not TNF-α were increased compared to controls, although not reaching the high levels found in bacterial meningitis. No correlation was found between the concentrations or the ratios of any pair of KYN metabolites and any cytokine or standard cytochemical parameter tested.
CNS infection with meningococci, pneumococci, and enteroviruses intrathecally activate the KYN pathway, favoring its neurotoxic branch. However, in PM, higher CSF levels of QUINA, compared to MM and VM, may contribute to its poorer neurologic outcome.
The effect of electroconvulsive therapy (ECT) on serum kynurenine pathway metabolites in late-life depression
2023, Journal of Affective Disorders Reports
Depression is reportedly associated with alterations in kynurenine pathway metabolites (kynurenines). Several kynurenines are involved in glutamate signaling, and some have potentially neurotoxic effects while others are considered neuroprotective. The pathway is upregulated under inflammatory conditions, which is associated with depression. Modulation of kynurenine metabolism has been investigated as a potential mechanism in electroconvulsive therapy (ECT), an effective treatment for major depressive disorder, particularly in late-life depression. However, results have been inconclusive. Here we aimed to investigate changes in tryptophan and kynurenines in older patients treated with ECT.
We analyzed levels of tryptophan, eight kynurenine pathway metabolites and the inflammation marker neopterin in serum samples collected at baseline and after a full ECT series for 48 patients with late-life depression from the Dutch MODECT study.
There were no significant changes in the concentration of single metabolites after ECT, but a significant reduction in the ratio of kynurenic acid to 3-hydroxykynurenine (KA/HK). Analyses of change in kynurenines after ECT in remitters and non-remitters revealed no clear patterns or link to the therapeutic effect of ECT. There was considerable covariation between neopterin and several kynurenines.
Variations in diet and serum collection timing may have impacted the results.
This study did not show consistent changes in the kynurenine pathway activation or balance between neuroactive metabolites after ECT. Still, changes in kynurenines were strongly related to changes in neopterin concentrations. This demonstrates the importance of considering inflammation when investigating the effect of ECT on the kynurenine pathway.

View all citing articles on Scopus

View full text

ReviewMonitoring tryptophan metabolism in chronic immune activation

Abstract

Section snippets

Tryptophan metabolism

IDO to limit cellular growth via tryptophan deprivation

Measurement of tryptophan and kynurenine

Accelerated tryptophan catabolism due to IDO activation in patients

Pathogenetic effects related to accelerated tryptophan degradation

Treatment options to counteract accelerated tryptophan degradation

Conclusion

Acknowledgements

Life Sci

Biochim Biophys Acta

Trends Immunol

Immunol Lett

Clin Immunol

Clin Immunol

Cancer Lett

Immunobiology

Clin Biochem

Med Hypotheses

Brain Behav Immun

Psych Res

Lancet Infect Dis

Arch Biochem Biophys

Med Hypotheses

The relative importance of dietary tryptophan and preformed nicotinic acid and nicotinamide as precursors of nicotinamide nucleotide coenzymes

Induction of pulmonary indoleamine (2,3)-dioxygenase by interferon

Proc Natl Acad Sci U S A

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism

FASEB J

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

J Immunol

Induction of tryptophan degradation in vitro and in vivo: a gamma interferon stimulated activity

J Interferon Res

Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells

Clin Exp Immunol

Tryptophan degradation in patients infected by human immunodeficiency virus

Biol Chem Hoppe-Seyler

Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms

J Aquir Immune Defic Syndr

Immune activation and degradation of tryptophan in coronary heart disease

Eur J Clin Invest

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

Clin Investig

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

Brain

Simultaneous measurement of serum tryptophan and kynurenine by HPLC

Clin Chem

Interferon-?-induced conversion of tryptophan: immunologic and neuropsychiatric aspects

Curr Med Chem

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

Proc Natl Acad Sci U S A

Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media

Cancer Res

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

Proc Natl Acad Sci U S A

Inhibition of T cell proliferation by macrophage tryptophan catabolism

J Exp Med

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

Science

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

J Exp Med

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase

J Exp Med

More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC

Clin Chem

Indoleamine 2,3-dioxygenase expression in monocytes of healthy nonpregnant women after induction with human choriongonadotropine

Scand J Immunol

Interferon-gamma-induced tryptophan degradation: neuropsychiatry and immunological consequences

Curr Drug Metabol

Review
Monitoring tryptophan metabolism in chronic immune activation